Kellett Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
HCM
AAMU
FWCM
AAIS
Kellett Wealth Advisors's ABBV Position: Q2 2026 in Review
Kellett Wealth Advisors increased its AbbVie (ABBV) stake by 2.8% in Q2 2026, buying an estimated $20.2K and bringing the position to 3,424 shares worth $862K. The position accounts for 0.4% of the portfolio, ranked #33.
Kellett Wealth Advisors first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Kellett Wealth Advisors held 3,424 shares of AbbVie worth $862K as of Q2 2026.
- Kellett Wealth Advisors bought 94 AbbVie shares in Q2 2026, an estimated $20.2K.
- AbbVie made up 0.4% of Kellett Wealth Advisors's portfolio in Q2 2026, its #33 holding.
- Kellett Wealth Advisors first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 1,601 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Kellett Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.